Čeština 
Slovenčina 
Română 
Deutsch ANAU
Treatment of adult patients with diabetes mellitus II. type.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains sitagliptin hydrochloride monohydrate, equivalent to 25 mg sitagliptin.
PHARMACEUTICAL FORM
Film-coated tablet.
THERAPEUTIC INDICATIONS
For adult patients with type 2 diabetes mellitus, Anau is indicated to improve glycaemic control as:
- monotherapy,
- dual oral therapy in combination,
- triple oral therapy in combination.
Anau is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.
DISPENSING AND REIMBURSEMENT
Medicinal product is subjected to medical prescription. The medicinal product is covered by public health insurance.
Mandatory information
